Nobody can answer that.
Why is this moving backwards? Let's start with Valient. Late quarterly reporting. Absent CEO during questionable business practices. Lower guidance after late report.
Other big pharma companies moving over seas.
Politicians promising to bring Healthcare companies to thier knees.
Unrealistic drug price hikes.
I'm sure I left plenty of other developments out.
Now a question for you Benjamin.
How much of this sounds favorable for sector growth?